Getinge AB (publ) ( GNGBY) - Stock Earnings
GNGBY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 59.2 million USD | 860.5 million USD |
| 2025Q4 | 94.3 million USD | 1.1 billion USD |
| 2026Q1 | 41.9 million USD | 777.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
GNGBY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 239.5 million USD | 3.2 billion USD |
| 2024 | 148.9 million USD | 3.2 billion USD |
| 2025 | 245.2 million USD | 3.8 billion USD |
| 2026 Est. | — | — |
GNGBY
Price: $20.03
Forward Dividend Yield: 1.42%
Payout Ratio: 45.26%
Dividend Per Share: 0.28 USD
Earnings Per Share: 0.91 USD
P/E Ratio: 21.41
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Country: Sweden
Volume: 7753
Ebitda: 698.1 millionMarket Capitalization: 5.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 16
DGR3: 6.00%
DGR5: 30.00%
DGR10: 27.89%